Minqiang Liu, Hong Gao, Jingyu Chen, Yanjuan Wang, Bo Xu, Guilong Wang, Qiang Wu, Chunxiao Hu
Department of Anesthesiology, The Third People's Hospital of Shenzhen, No. 29 Bulan Road, Longgang District, Shenzhen, Guangdong 518112, China.
Department of Anesthesiology, Wuxi People's Hospital, 299 Qingyang Road, Liangxi District, Wuxi, Jiangsu 214023, China.
Case Rep Med. 2020 Feb 12;2020:7265429. doi: 10.1155/2020/7265429. eCollection 2020.
Extracorporeal membrane oxygenation (ECMO) is a widely used cardiopulmonary support method that is usually implemented after anesthesia during the period of lung transplantation (LTx). In severe pulmonary arterial hypertension (PAH) patients, however, anesthesia induction is a high-risk phase and can result in severe cardiorespiratory failure. Herein, we describe two severe PAH patients who received ECMO support before anesthesia and whose preoperative evaluations indicated that the risk was too high to safely survive the anesthesia induction period before LTx. The strategy was successful, and in both patients, hemodynamics was stable and no ECMO-related complications occurred.
体外膜肺氧合(ECMO)是一种广泛应用的心肺支持方法,通常在肺移植(LTx)期间麻醉后实施。然而,在重度肺动脉高压(PAH)患者中,麻醉诱导是一个高风险阶段,可能导致严重的心肺衰竭。在此,我们描述了两名重度PAH患者,他们在麻醉前接受了ECMO支持,术前评估表明风险过高,无法在LTx前安全度过麻醉诱导期。该策略取得了成功,两名患者的血流动力学均稳定,未发生与ECMO相关的并发症。